logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Krsnaa Diagnostics Ltd

Krsnaa Diagnostics

Small Cap•3,700 Employees•IPO 2021
Current Price
₹610.55
-0.8 (-0.13%)Updated
NSE :KRSNAA
BSE :543328
Sector :Health Care Providers & Services
Today's Range
₹605.95
₹610.55
union icon
₹619.85
52 Week Range
52W Low₹598.00
52W High₹894.40
₹610.55
union icon
Downside2.10%
Upside46.49%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹2,173.72 Cr
Market Cap
Total market value of company
P/E Ratio
25.55
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
2.66
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹25.68
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
4.94%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
11.90%
ROCE
Return on Capital Employed. >15% is good
Net Margin
11.13%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
22.65%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
13.40%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
14.50%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.23
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹273.39
Book Value
Net asset value per share
Dividend Yield
0.38%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
27.10%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

4 points
  • •Krsnaa Diagnostics shows robust quarterly sales growth of 13.40% and profit growth of 14.50%, indicating strong operational efficiency and increasing market demand for its diagnostic services.
  • •The company maintains a healthy operating profit margin (OPM) of 26.90%, reflecting effective cost management and strong pricing power in the competitive healthcare sector. This is supported by an 8.76% Return on Equity.

Weaknesses

4 points
  • •Promoter holding is relatively low at 27.11% (as of 2025-09-01), which could raise concerns about management control or potential future dilution, potentially impacting long-term investor confidence.
  • •The company's price-to-book value of 2.89 suggests the market prices Krsnaa Diagnostics at a premium to its net asset value, potentially indicating high investor expectations or a degree of overvaluation.

Opportunities

3 points
  • •The expanding healthcare sector and rising demand for diagnostic services in India present significant growth avenues for Krsnaa, allowing for market penetration and service expansion.
  • •Leveraging its established presence, Krsnaa can explore expansion into underserved regions or new urban centers, capitalizing on the increasing accessibility and demand for quality diagnostic facilities.

Threats

4 points
  • •The diagnostic services industry is highly competitive, with established players and new entrants potentially leading to pricing pressures and market share erosion for Krsnaa Diagnostics.
  • •Changes in healthcare regulations, pricing policies, or government initiatives could impact Krsnaa's operational costs and revenue streams, posing a significant external risk to profitability.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Krsna Diagnostics (Mumbai) Private Limited
27 Dec 202431 Dec 20247.66 L
22,929
₹870.89BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹646.08+₹35.53+5.82%
R3₹632.18+₹21.63+3.54%
R2₹626.02+₹15.47+2.53%
R1₹618.28+₹7.73+1.27%
PIVOT₹612.121.570.26%
CURRENT₹610.55--
S1₹576.58-₹33.97-5.56%
S2₹590.48-₹20.07-3.29%
S3₹598.22-₹12.33-2.02%
S4₹604.38-₹6.17-1.01%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
0.38L
(06 Mar 2026)
-53.5% vs avg
Delivery %
71.0%
(06 Mar 2026)
+11.0% vs avg
Avg Volume (20D)
0.82L
(06 Feb - 06 Mar)
20-day average
Avg Delivery %
60.0%
(06 Feb - 06 Mar)
Trend ↓
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Dr Lal Pathlabs Ltd
24,046.66 ₹ Cr
Best Profit Growth
Thyrocare Technologies Ltd
79.90 %
Highest Dividend Yield
Thyrocare Technologies Ltd
1.66 %

Peer Comparison

Company Name
LALPATHLAB
Dr Lal Pathlabs Ltd
METROPOLIS
Metropolis Healthcare Ltd
SURAKSHA
Suraksha Diagnostic Ltd
THYROCARE
Thyrocare Technologies Ltd
VIJAYA
Vijaya Diagnostic Centre Ltd

About

KRSNAA

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited is a prominent provider of diagnostic services across India, specializing in a comprehensive range of medical testing and imaging solutions. Their service portfolio encompasses a wide spectrum of diagnostic modalities, catering to the diverse needs of both individual patients and institutional clients. This diverse offering positions them as a significant player in the Indian healthcare landscape.

The company's core services fall under three major categories: radiology, pathology, and teleradiology. Radiology services likely encompass various imaging techniques such as X-rays, CT scans, MRIs, and ultrasound, providing detailed anatomical images for diagnosis. Pathology services involve the analysis of bodily fluids and tissues to detect diseases and abnormalities at a cellular level. Teleradiology, a crucial aspect of their offerings, allows for the remote interpretation of medical images, enabling the efficient dissemination of diagnostic expertise across geographically dispersed areas and improving access to specialist opinion.

Beyond individual tests, Krsnaa Diagnostics also offers a suite of pre-packaged health check-ups designed to assess specific health concerns or cater to particular demographics. These packages address common health issues, covering areas such as diabetes, heart health, liver function, kidney function, thyroid health, cancer risk assessment, and more. They also offer specialized packages targeting specific age groups, like senior citizen health checks, and address common conditions such as infections and fatigue. This targeted approach enhances accessibility and convenience for patients seeking preventative healthcare or focused diagnostic evaluations.

Krsnaa Diagnostics serves a broad client base, including public and private hospitals, medical colleges, and community health centers. This diverse clientele highlights their adaptability and significance within the healthcare ecosystem. Their reach across various healthcare sectors demonstrates their ability to meet the diagnostic needs of a wide range of patients and medical institutions. This widespread network positions them as a key contributor to the overall quality and accessibility of healthcare in India.

Established in 2010 and headquartered in Pune, India, Krsnaa Diagnostics has developed a strong presence within the country's diagnostic services sector. Their comprehensive service portfolio, coupled with their broad client base, positions them as a significant player in the Indian healthcare market, contributing to improved diagnostic capabilities and healthcare access across various segments of the population.

COMPANY FACTS - KRSNAA

Registered Address

S.No.243,A-Hissa No.6/6 CTS No.4519, Near Mayur Trade Centre, Chinchwad

Pune

MAHARASHTRA

IN

Tel: 919623396233

Website:https://krsnaadiagnostics.com/

Investor Relations:http://www.krsnaadiagnostics.com/investors/
Company Details

Group: Health Care Equipment & Services

Sector: Health Care

Industry: Health Care Providers & Services

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 3,700

IPO Date: 16/08/2021

MANAGEMENT - KRSNAA

Mr. Rajendra Mutha

Executive Chairman

Mr. Mitesh Dave

Group Chief Executive Officer

Mr. Pawan Daga

Chief Financial Officer

Dr. Ravinder Sethi

Chief Operating Officer

Mr. Sujoy Bose

Compliance Officer, Company Secretary

Mr. Dharmendra Sharma

Vice President - Operations

Dr. Abhijeet Patil

Vice President - Radiology

Ms. Pallavi Bhatevara

Executive Director

Dr. Manish Karekar

Chief Operating Officer - Pathology

Mr. Prem Pradeep

Independent Nominee Director

Mr. Chetan Desai

Non-Executive Independent Director

Mr. Adesh Gupta

Non-Executive Independent Director

Investor Questions Answered

Krsnaa Diagnostics Ltd (KRSNAA) Stock FAQs

Get answers to the most common questions about Krsnaa Diagnostics Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Krsnaa Diagnostics Ltd (KRSNAA) is ₹610.55. Today, the stock has declined by ₹0.80 (0.13%), trading in a range of ₹605.95 to ₹619.85. The stock opened at ₹610 with a trading volume of 38,273 shares.
Krsnaa Diagnostics Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,173.72 crores, P/E ratio of 25.55, ROE of 4.94%, and ROCE of 11.90%. The dividend yield stands at 0.38%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Krsnaa Diagnostics Ltd (KRSNAA) is ₹894.4, while the 52-week low is ₹598. Currently trading at ₹610.55, the stock is 4.2% away from its 52-week low and 31.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Krsnaa Diagnostics Ltd stock at ₹610.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 25.55 and P/B ratio of N/A. Today's performance shows a loss of 0.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Krsnaa Diagnostics Ltd offers a dividend yield of 0.38%, which means for every ₹100 invested at the current price of ₹610.55, you can expect to receive approximately ₹0.38 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Krsnaa Diagnostics Ltd's key financial metrics include: P/E Ratio: 25.55, P/B Ratio: N/A, ROE: 4.94%, ROCE: 11.90%, Dividend Yield: 0.38%, EPS: ₹25.68, Book Value: ₹273.39, Debt-to-Equity: 0.23, and Current Ratio: N/A. The company's market cap stands at ₹2,173.72 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Krsnaa Diagnostics Ltd stock opened at ₹610 and is currently trading at ₹610.55, showing a decline of ₹0.80 (0.13%). The intraday high is ₹619.85 and low is ₹605.95. The trading volume stands at 38,273 shares, indicating moderate market participation today.
Krsnaa Diagnostics Ltd has a Price-to-Earnings (P/E) ratio of 25.55, which means investors are willing to pay ₹25.55 for every ₹1 of earnings. With an EPS of ₹25.68, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Krsnaa Diagnostics Ltd has a market capitalization of ₹2,173.72 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹610.55) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Krsnaa Diagnostics Ltd has a book value of ₹273.39 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹610.55, which is 123.3% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Krsnaa Diagnostics Ltd has a Return on Equity (ROE) of 4.94% and Return on Capital Employed (ROCE) of 11.90%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Krsnaa Diagnostics Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Krsnaa Diagnostics Ltd has a debt-to-equity ratio of 0.23, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Krsnaa Diagnostics Ltd has an Earnings Per Share (EPS) of ₹25.68, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹610.55 and P/E ratio of 25.55, investors are paying 25.55 times the annual earnings per share. This moderate EPS suggests decent earnings generation. Track EPS growth over quarters to assess earnings momentum.
Krsnaa Diagnostics Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Krsnaa Diagnostics Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Krsnaa Diagnostics Ltd stock, consider: 1) Fundamental Analysis - Review P/E (25.55), ROE (4.94%), debt-to-equity (0.23), and growth rates. 2) Technical Analysis - Check 52-week range (₹598.00 - ₹894.40), moving averages, and chart patterns. 3) Valuation - Compare current price (₹610.55) with book value (₹273.39) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Krsnaa Diagnostics Ltd share is ₹5.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹610.55 is 12111x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Krsnaa Diagnostics Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹598.00 - ₹894.40). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.23 indicates leverage. 4) Liquidity Risk - Based on trading volume of 38,273 shares. 5) Valuation Risk - P/E of 25.55 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Krsnaa Diagnostics Ltd operates in the industry with key metrics: P/E ratio of 25.55, ROE of 4.94%, market cap of ₹2,173.72 crores, and dividend yield of 0.38%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.23), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Krsnaa Diagnostics Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹610.55, with a 52-week range of ₹598.00 to ₹894.40. Based on fundamentals like P/E (25.55), ROE (4.94%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Krsnaa Diagnostics Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹610.55. 2) Fundamental Deterioration - Declining ROE (currently 4.94%), increasing debt (D/E: 0.23), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Krsnaa Diagnostics Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.38%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.